Edition:
United States

Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

73.74USD
4:00pm EDT
Change (% chg)

$0.41 (+0.56%)
Prev Close
$73.33
Open
$73.62
Day's High
$74.48
Day's Low
$73.37
Volume
875,250
Avg. Vol
799,292
52-wk High
$75.61
52-wk Low
$58.89

Latest Key Developments (Source: Significant Developments)

Baxter Expects Sales To Grow ~5 Pct On Compounded Annual Basis At Constant Currency Rates From 2018 To 2023
Monday, 21 May 2018 08:00am EDT 

May 21 (Reuters) - Baxter International Inc ::BAXTER HIGHLIGHTS BUSINESS STRATEGIES AND INNOVATION AT 2018 INVESTOR CONFERENCE.BAXTER INTERNATIONAL INC - BAXTER EXPECTS TO GROW SALES 4 TO 5 PERCENT ON A COMPOUNDED ANNUAL BASIS AT CONSTANT CURRENCY RATES FROM 2018 THROUGH 2020.BAXTER INTERNATIONAL INC - NOW EXPECTS A 2020 ADJUSTED OPERATING MARGIN OF 20 TO 21 PERCENT AND ADJUSTED DILUTED EARNINGS OF $3.60 TO $3.75 PER SHARE.BAXTER INTERNATIONAL INC - NOW EXPECTS FREE CASH FLOW (OPERATING CASH FLOW LESS CAPITAL EXPENDITURES) OF APPROXIMATELY $2.1 BILLION IN 2020.BAXTER INTERNATIONAL - EXPECTS SALES TO GROW APPROXIMATELY 5 PERCENT ON A COMPOUNDED ANNUAL BASIS AT CONSTANT CURRENCY RATES FROM 2018 TO 2023.BAXTER INTERNATIONAL - IN 2023, ANTICIPATES AN ADJUSTED OPERATING MARGIN OF 23 TO 24 PERCENT AND ADJUSTED DILUTED EARNINGS OF $4.90 TO $5.05 PER SHARE.BAXTER INTERNATIONAL INC - ALSO EXPECTS TO GENERATE FREE CASH FLOW OF APPROXIMATELY $2.65 BILLION IN 2023.  Full Article

Baxter Reports Q4 Adjusted EPS Of $0.64​
Thursday, 1 Feb 2018 07:15am EST 

Feb 1 (Reuters) - Baxter International Inc ::BAXTER REPORTS 2017 FOURTH-QUARTER AND FULL-YEAR RESULTS.Q4 GAAP LOSS PER SHARE $0.11 FROM CONTINUING OPERATIONS.Q4 REVENUE $2.8 BILLION VERSUS I/B/E/S VIEW $2.77 BILLION.Q4 EARNINGS PER SHARE VIEW $0.59 -- THOMSON REUTERS I/B/E/S.SEES Q1 EARNINGS PER SHARE $0.60 TO $0.62 FROM CONTINUING OPERATIONS EXCLUDING ITEMS.SEES FY 2018 EARNINGS PER SHARE $2.72 TO $2.80 FROM CONTINUING OPERATIONS EXCLUDING ITEMS.Q4 WORLDWIDE SALES TOTALED ABOUT $2.8 BILLION, UP 5 PERCENT ON REPORTED BASIS, 3 PERCENT ON CONSTANT CURRENCY BASIS​.BAXTER - Q4 REVENUE NEGATIVELY IMPACTED BY ABOUT $70 MILLION FROM TEMPORARY MANUFACTURING DISRUPTIONS IN PUERTO RICO DUE TO IMPACT OF HURRICANE MARIA.QTRLY ‍ADJUSTED EPS OF $0.64​.QTRLY ‍SALES IN U.S. WERE $1.1 BILLION, INCREASING 1 PERCENT​.BAXTER INTERNATIONAL - QTRLY ‍INTERNATIONAL SALES TOTALED MORE THAN $1.6 BILLION, REPRESENTING 8 PERCENT INCREASE ON REPORTED BASIS​.BAXTER - Q1 SALES WILL BE NEGATIVELY IMPACTED BY ABOUT $25 MILLION DUE TO DISRUTIONS IN PUERTO RICO.FOR FULL-YEAR 2018, BAXTER EXPECTS SALES GROWTH OF 6 TO 7 PERCENT ON A REPORTED BASIS.FOR Q1, COMPANY EXPECTS SALES GROWTH OF APPROXIMATELY 5 TO 6 PERCENT ON A REPORTED BASIS.BAXTER - ALL PUERTO RICO FACILITIES ARE BACK ON ELECTRICAL GRID & HAVE BEEN RAMPING UP PRODUCTION TO PRE-HURRICANE LEVELS.FOR Q1, OPERATIONAL SALES ARE EXPECTED TO BE FLAT TO UP 1 PERCENT AS COMPARED TO PRIOR-YEAR PERIOD.SEES ‍Q1 2018 GAAP EARNINGS PER SHARE $0.45 - $0.49​.  Full Article

Mallinckrodt Will Sell Recothrom, Preveleak To Baxter for $185 Mln
Monday, 8 Jan 2018 07:45am EST 

Jan 8 (Reuters) - Mallinckrodt Plc :MALLINCKRODT WILL SELL RECOTHROM® AND PREVELEAK® TO BAXTER.MALLINCKRODT - TOTAL DEAL CONSIDERATION OF $185 MILLION, WITH $153 MILLION UPFRONT, INCLUDING EXISTING INVENTORY, REMAINDER IN POTENTIAL MILESTONE PAYMENTS.MALLINCKRODT PLC - WILL RETAIN RAPLIXA FOR TOPICAL USE AND IS EVALUATING STRATEGIC OPTIONS FOR THIS PRODUCT.MALLINCKRODT - ‍ SALE IS ANTICIPATED TO DILUTE CO'S ADJUSTED EARNINGS PER SHARE BY $0.10 TO $0.15 IN 2018, WHICH WILL BE OFFSET BY SHARES REPURCHASED DURING Q4 2017​.MALLINCKRODT PLC - COMPANY WILL DISCONTINUE MARKETING OF RAPLIXA UPON CLOSE OF BAXTER TRANSACTION.MALLINCKRODT PLC - PROCEEDS FROM SALE WILL BE USED BY COMPANY TOWARD PAYING DOWN DEBT.MALLINCKRODT PLC - ‍WRITE-OFF FOR RAPLIXA​ WILL BE REPORTED FOR Q4 2017.  Full Article

Baxter To Acquire Recothrom, Preveleak For Upfront Payment Of About $153 Mln
Monday, 8 Jan 2018 07:45am EST 

Jan 8 (Reuters) - Baxter International Inc ::BAXTER ANNOUNCES AGREEMENT TO BROADEN PORTFOLIO OF INNOVATIVE SURGICAL PRODUCTS.BAXTER INTERNATIONAL - TO ACQUIRE RECOTHROM AND PREVELEAK FOR UPFRONT PAYMENT OF ABOUT $153 MILLION AND POTENTIAL CONTINGENT PAYMENTS IN FUTURE.BAXTER INTERNATIONAL - UPON CLOSING, DEAL EXPECTED TO BE MODESTLY ACCRETIVE TO BAXTER'S 2018 ADJUSTED EPS & INCREASINGLY ACCRETIVE THEREAFTER.BAXTER INTERNATIONAL - ‍PROPOSED DEAL INCLUDES TWO HEMOSTAT & SEALANT PRODUCTS, INCLUDING STAND-ALONE RECOMBINANT THROMBIN, SURGICAL SEALANT​.  Full Article

Baxter sees Q4 revenue to be negatively impacted by about $70 mln due to temporary manufacturing disruptions resulting from Hurricane Maria​
Wednesday, 25 Oct 2017 07:15am EDT 

Oct 25 (Reuters) - Baxter International Inc :Baxter reports third-quarter 2017 results and updates financial outlook for full-year 2017.Q3 GAAP earnings per share $0.45 from continuing operations.Q3 revenue $2.7 billion versus I/B/E/S view $2.66 billion.Q3 earnings per share view $0.59 -- Thomson Reuters I/B/E/S.Sees Q4 earnings per share $0.56 to $0.59 from continuing operations excluding items.Sees FY 2017 earnings per share $2.40 to $2.43 from continuing operations excluding items.Sees FY 2017 GAAP earnings per share $1.85 to $1.93.Baxter International Inc - ‍qtrly sales within U.S. were approximately $1.1 billion, advancing 8 percent​.Baxter International - Sees Q4 revenue to be negatively impacted by about $70 million due to temporary manufacturing disruptions resulting from Hurricane Maria​.Baxter - Qtrly ‍international sales about $1.6 billion, representing a 5 percent increase on reported basis and a 4 percent increase on a constant currency basis​.Baxter International - ‍For FY 2017, co now expects sales growth of about 4 percent on a reported basis, about 4 percent on a constant currency basis​.Q3 adjusted earnings per share $0.64 from continuing operations excluding items.Baxter International Inc - ‍Remains in limited production across all three manufacturing sites in Puerto Rico​.FY2017 earnings per share view $2.39, revenue view $10.50 billion -- Thomson Reuters I/B/E/S.  Full Article

Baxter provides update on Puerto Rico recovery status post Hurricane Maria
Thursday, 12 Oct 2017 04:15pm EDT 

Oct 12 (Reuters) - Baxter International Inc :Baxter provides update on Puerto Rico recovery status post Hurricane Maria.Baxter International Inc - ‍company expects to mitigate earnings impact from Hurricane Maria​.Baxter International Inc - ‍resumed limited production at all Puerto Rico manufacturing sites​.Baxter International Inc - ‍Baxter's three Puerto Rico manufacturing sites sustained minimal structural damage from impact of Hurricane Maria​.Baxter - co granted discretion for temporary importation of some products from facilities in Ireland, Australia to support product supply for U.S. market​.Baxter International Inc - ‍company does not manufacture large volume sterile solutions, such as its 1 liter IV solutions, in Puerto Rico​.  Full Article

Baxter International Inc - ‍launches DeviceVue Advanced Asset Tracking System for Sigma Spectrum Infusion System​
Wednesday, 27 Sep 2017 08:00am EDT 

Sept 27 (Reuters) - Baxter International Inc :Baxter International Inc - ‍launches DeviceVue Advanced Asset Tracking System for Sigma Spectrum Infusion System​.  Full Article

Baxter International ‍announces commercial launch of new indication for oXiris set​
Tuesday, 26 Sep 2017 08:55am EDT 

Sept 26 (Reuters) - Baxter International Inc : :Baxter launches first 3-in-1 set for use in continuous renal replacement therapy and sepsis management protocols.Baxter International Inc - ‍announced commercial launch of a new indication for company's oXiris set​.Baxter International Inc - ‍Baxter currently plans to file for expanded indication for oXiris set in additional countries in 2018 and beyond​.  Full Article

Baxter and MATTER Healthcare on patient-driven innovation
Thursday, 31 Aug 2017 08:30am EDT 

Aug 31 (Reuters) - Baxter International Inc :Baxter and MATTER Healthcare Incubator Partner on patient-driven innovation.Baxter International Inc - ‍ as part of agreement will gain access to MATTER's extensive program suite.​.  Full Article

Baxter reports second-quarter 2017 results
Wednesday, 26 Jul 2017 07:15am EDT 

July 26 (Reuters) - Baxter International Inc :Baxter reports second-quarter 2017 results and provides updated financial outlook for 2017 and 2020.Sees FY 2020 adjusted earnings per share $3.25 to $3.40.Q2 GAAP earnings per share $0.48 from continuing operations.Q2 revenue $2.6 billion versus I/B/E/S view $2.59 billion.Q2 earnings per share view $0.57 -- Thomson Reuters I/B/E/S.Sees FY 2017 earnings per share $2.34 to $2.40 from continuing operations excluding items.Sees Q3 earnings per share $0.58 to $0.60 from continuing operations excluding items.Sees FY 2017 GAAP earnings per share $1.85 to $1.95.Baxter International Inc says financial outlook for 2020 increased to reflect strong operational execution and ongoing business transformation initiatives.Q3 earnings per share view $0.56 -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $2.27 -- Thomson Reuters I/B/E/S.Baxter International Inc says Q2 sales within U.S. were $1.1 billion, advancing 4 percent.Baxter International Inc - for FY2017 raising financial outlook for year and now expects sales growth of approximately 3 percent on a reported basis.Company expects sales growth of approximately 4 percent on a reported basis for Q3.Baxter - Q2 international sales totaled about $1.5 billion, representing a 2 percent decrease on reported basis and 1 percent increase on a constant currency basis.Baxter International Inc - expects sales to grow approximately 4 percent on a compounded annual basis from 2016 to 2020.  Full Article